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Objective: The purpose of this study was to develop a protocol for evaluation of patients suspected of having deep venous
thrombosis (DVT) who came to the hospital after normal noninvasive vascular laboratory (NIVL) working hours in an
attempt to both retain registered vascular therapists and provide excellent patient care.
Methods: We developed a protocol for evaluation of patients suspected of having DVT who were seen at night after normal
NIVL working hours (8 am to 9 pm). After exclusion of those with contraindications, all eligible patients either received
low–molecular weight heparin (LMWH; 1 mg/kg) and were sent home or were placed at bedrest in the emergency
department until the NIVL opened the following morning. Those sent home were given maps to the NIVL and told what
time to report. Parameters examined were numbers of after-hours venous duplex ultrasonography (VDU) studies, patient
morbidity and mortality, and RVT retention. We compared results from October 1, 1997, through September 30, 1998,
the year before the program started, with those from October 1, 1998, through September 30, 2000, the 2 years after
program implementation. Data were compared with 2 analysis.
Results: During the study period, 161 patients suspected of having DVT were seen at the NIVL after hours and were
deferred for study until the morning. Eighty-eight patients received prophylactic LMWH and were sent home, and 73
patients were placed in observation. All had VDUs the next morning at 8 am. No deaths, pulmonary emboli, or immediate
complications of anticoagulation therapy were seen. After implementation, we noted an 89% reduction in after-hours
VDU studies. Before program implementation, four RVTs resigned during an 18-month period because of issues relating
to excessive call. From 1998 through 2000, the NIVL had 100% retention of its nine RVTs.
Conclusion: The development of the LMWH program has reduced after-hours VDUs by 89% without causing patient
morbidity or mortality. Retention of RVTs has been 100% since program implementation. (J Vasc Surg 2002;36:132-6.)
Venous duplex ultrasonography (VDU) has become
the standard initial study for the diagnosis of deep vein
thrombosis (DVT) in both the inpatient and outpatient
settings because of its ease and accuracy.1,2 The reliability
and noninvasive nature of VDU has resulted in increased
volumes of studies in most noninvasive vascular laborato-
ries (NIVL), especially those in hospitals.3,4 Unfortunately,
this increased volume of VDU studies can burden a NIVL
in a large tertiary hospital, especially after routine working
hours when the NIVL is not usually staffed by registered
vascular technologists (RVTs). Maintenance of 24-hour
coverage can stress a facility’s capacity to sustain a high-
quality NIVL by affecting the ability of the NIVL to retain
qualified RVTs, especially when competing with NIVLs
that do not require on-call duties. The 24-hour coverage
can also affect both the financial status of the NIVL and the
ability of the NIVL to support a busy vascular surgery
program’s needs and goals.
To find a method to allow our hospital NIVL to
continue to offer 24-hour studies and at the same time
reduce the number of after-hour studies, we developed a
protocol in which selected patients referred after routine
NIVL working hours for a VDU study to rule out DVT
were given low–molecular weight heparin (LMWH) and
sent home or were assigned to bedrest and observation in
the emergency department (ED). The VDU studies for
these selected patients were then deferred until the follow-
ing morning, during routine NIVL working hours. The
purpose of this study was to assess the effect of this program
on (1) the number of after-hours VDU studies, (2) mor-
bidity and mortality to patients in the protocol, and (3)
RVT retention.
METHODS
In October 1998, the NIVL of Greenville Memorial
Hospital adopted an after-hours algorithm to help physi-
cians with treatment of a patient suspected of having DVT
who was seen after hours for VDU (Fig 1). The vascular
laboratory at Greenville Memorial Hospital, a tertiary-care
hospital located in Greenville, SC, is accredited by the
Intersocietal Commission for the Accreditation of Vascular
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Laboratories and performs more than 12,000 examinations
(including approximately 2900 VDUs) annually. The lab-
oratory is staffed by nine RVTs. The inpatient portion of
the laboratory serves the needs of the 768-bed hospital, and
the outpatient laboratory supports a large hospital-based
vascular surgery practice and the general population of
Upstate South Carolina. The laboratory is the only NIVL in
the area that provides 24-hour coverage.
We used the algorithm to educate physicians about the
relative merits of immediate after-hours VDU studies ver-
sus two other options: 1, beginning outpatient LMWH
therapy and sending the patient home overnight; or 2,
observing the patient overnight in the ED. Both latter
groups had a VDU study performed the following morn-
ing. Because selected patients would be subjected to the
inherent risks of anticoagulation therapy, a list of contrain-
dications to the use of LMWH was developed (Fig 2). Both
the algorithm and the contraindications list were developed
in section and department meetings to help ensure physi-
cian participation. They then were approved and adopted
by the physicians who interpreted NIVL studies and by the
ED physicians. Before study implementation, we informed
the entire medical staff of the hospital of the program and
asked them to comply with it when possible. After the start
of the study, all after-hours VDU requests were screened by
the physician on call for the NIVL and all referring physi-
cians with eligible patients were encouraged to follow the
protocol.
If the referring physician suspected that a patient seen
after 9 pm had DVT and the patient had no contraindica-
tions, the physician (usually an ED physician) gave the
patient LMWH (enoxaparin [Lovenox], Aventis, Parsi-
panny, NJ) at a dose of l mg/kg of actual body weight. The
referring physician filled out an outpatient DVT worksheet
(Fig 3) and gave it to the patient, who brought it to the
NIVL the next morning. All patients were instructed to stay
at bedrest. Patients who had been sent home after LMWH
and referred to the NIVL the following morning were
supplied with directions and maps to the two locations of
the NIVL. A voice-mail system was used to inform the
RVTs in the laboratory about patients who would return
for VDU studies. These patients’ venous duplex scans then
were performed as the first studies of the day during regular
laboratory hours (8 am to 9 pm) within the 12-hour
anticoagulation window of LMWH.
Physicians who referred patients to the NIVL for VDU
after 9 pm were not required to give patients anticoagula-
tion therapy, or if they did, they used LMWH or sodium
heparin as they preferred. They had the option of allowing
patients to remain in the ED or placing patients in a clinical
decision unit until 8 am. Physicians also could request
after-hours VDUs. All NIVL studies ordered after 9 pm
required direct verbal communication between the order-
ing physician and the interpreting physician on call for the
NIVL (an RVT could not be called into the hospital for a
VDU without the verbal consent of the NIVL physician on
call). The NIVL physician on call also was required to
return to the hospital to provide the immediate interpreta-
tion of the VDU study. In addition, the physician staff of
the NIVL periodically monitored the program through the
use of outcome measures to assure the safety of patients on
the protocol.
In this retrospective analysis, we reviewed data ob-
tained between October 1, 1997, and September 30, 1998
(the year immediately before the start of the program), and
between October 1, 1998, and September 30, 2000 (the 2
years immediately after the program was implemented).
Parameters examined included the number of after-hours
VDUs performed, the number of protocol (delayed) VDUs
performed, the number of patients with positive ultrasound
scan results for DVT, the number of patients enrolled in the
protocol in whom pulmonary embolus developed, death,
and the retention rate for the RVTs. A duplex scan was
considered to be positive when established diagnostic cri-
teria for DVT were met.5 Patients were followed until the
VDU was completed.
RESULTS
During all years reviewed (October 1, 1997, through
September 30, 2000), 8538 VDU examinations for the
diagnosis of DVT were performed: 2667 for 1997 to 1998,
2911 for 1998 to 1999, and 2960 for 1999 to 2000. Of
Fig 1. Algorithm for treatment of patients with suspected DVT. CDU, Clinical decision unit.
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these, 8376 (98%) were performed during the NIVL’s
regular hours. An analysis of after-hours VDU studies for all
3 years is shown in the Table. After inception of the program,
30 patients, all with contraindications for LMWH use, under-
went emergent study after hours and 161 patients thought to
have DVT were referred to the NIVL after 9 pm by a physician
and had their examinations deferred until 8 am the following
morning. Of these 161 patients with deferred VDUs, 88
patients (55%) received LMWH, were sent home, and were
seen at the laboratory the following morning; 73 patients
(45%) were placed at bedrest in the ED’s critical decision unit
and underwent study at 8 am. The decision to give LMWH
and send home versus keep at bedrest in the ED was made by
the referring physician. Factors that influenced this decision
included the time of presentation (patients in the early morn-
ing hours, closer to 8 am, were often kept until 8 am), the level
of concern for DVT by the referring physician, the likelihood
the patient would return for the study, and the reluctance to
give certain patients anticoagulation therapy. All patients sent
home after injection with LMWH did indeed return to the
NIVL; no patient was lost in follow-up after initial physician
evaluation.
During the year before initiation of the protocol, 132
after-hours studies, resulting in 132 technologist call-
backs, were performed. The positive DVT rate of these
studies was 6%. In addition to reducing the number of
after-hour VDUs and technologist call-backs by 89%, the
implementation of the protocol resulted in a significantly
higher VDU specificity (37% positive versus 6% positive;
P  .001) in studies performed after hours.
Since the implementation of the program, no deaths,
clinically evident pulmonary emboli, or complications of
anticoagulation therapy have been attributable to the
protocol. Of the 161 patients with delayed VDUs, only
two (1.2%) had positive study results for DVT. In con-
trast, of the 30 patients who had contraindications for
the protocol or whose physicians insisted on emergency
examinations during the night, 11 (37%) had positive
studies for DVT, a difference that was statistically signif-
icant (P  .001).
Analysis of personnel turnover in the NIVL during the
12-month period before implementation of the protocol
revealed that four RVTs resigned from the NIVL; all went
to work in competing local NIVLs. Exit interviews in each
case revealed various factors for the attrition. However, the
three most commonly cited reasons for resignation in-
cluded: 1, intolerance of after-hours call-backs in a market
in which competing NIVLs had no call responsibility; 2, the
perceived number of unindicated studies they had been
required to perform after hours (negative venous studies);
and 3, the lack of screening by NIVL physicians of cases
that resulted in automatic (and often perceived as unneces-
Fig 2. Contraindications to outpatient DVT treatment. PE, Pulmonary embolus; PUD, peptic ulcer disease; PLT,
platelet count.
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sary) RVT call-back. Since implementation of the protocol,
the NIVL has lost none of its complete staff of nine RVTs
during the 24-month period.
DISCUSSION
The success of this program decreased the NIVL after-
hours call-backs for VDU by 89%. That decrease has helped
maintain NIVL staff, who provide comprehensive coverage
for the hospital’s patient care needs.Patients had no com-
plications. Our retention of staff was 100%, and the savings
from RVT compensation to the hospital was approximately
$17,000 per year.
Similar programs might help other hospital-based
NIVLs, which, if like our NIVL, have two goals. The first is
to support the ongoing vascular surgery program’s clinical
need for quality arterial and venous studies, and the second,
and equally important, is to provide comprehensive service
for the hospital’s patient population. They cannot simply
close their doors at night as many private laboratories do
and abandon these two goals. The inability of NIVLs to
manage the amount of after-hours call-backs is a problem
for hospitals and clinics nationally. Not only does it cost
them more in overtime for call-backs, but it also results in
RVT dissatisfaction. If the most frequent reason for NIVL
call-back is the request for a VDU to evaluate for DVT, as
it is in our laboratory, the VDU represents a significant
problem that can limit a hospital’s or clinic’s ability to staff
and maintain a functioning high-quality NIVL in a busy
tertiary referral hospital.
This problem in South Carolina was further complicated
by a change in Medicare/Medicaid reimbursement laws that
mandated that payment would be made only if an RVT
performed the noninvasive imaging.6 Because our hospital-
based NIVL is the largest in the region and is the only 24-hour
full-service laboratory with a highly skilled pool of nine RVTs,
many of whom were found after expensive national searches, it
is the natural prey for private laboratories who lack the re-
sources and expertise to recruit and train their own RVTs.
Competition with private NIVLs that do not require after-
hour, weekend, or holiday working hours is difficult. The
objective of our program was to find a method to allow our
hospital to continue to offer necessary 24-hour NIVL studies
while at the same time reduce the number of after-hours RVT
call-backs for VDU studies. Therefore, we tried to find a
clinical method to decrease the number of after-hours studies
without affecting patient outcomes or overall NIVL perfor-
mance. If these results could be accomplished, it seemed
obvious that our RVT retention would improve and the
revenue spent on RVT overtime would decrease.
The success of the program necessitated a great deal of
physician education. The educational process was begun
initially with the ED physicians at their department meet-
Fig 3. Outpatient DVT worksheet.
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ings and continued as other physicians became familiar with
the program. This educational endeavor decreased the
knee-jerk reaction of ordering a VDU for every swollen leg.
This form of behavior modification in physician clinical
decision-making helped decrease nonurgent VDU studies.
Our education may have modified physician behavior
in another positive way. That the percentage of positive
VDU study results increased statistically in the after-hours
studies once the protocol was initiated is interesting. The
contraindications to outpatient DVT treatment list (Fig 2)
may have helped screen patients further and thus may have
resulted in a large number of positive after-hour VDU
studies. That the clinical diagnosis of DVT with physical
examination alone is inaccurate has long been observed,7,8
and other studies have attempted to risk stratifying patients
to limit after-hour DVT studies.9,10 Could this protocol
have improved the clinical acumen of the referring physi-
cians? Thirty-seven percent of the patients studied at night
after the program implementation had positive study re-
sults compared with only 6% of those studied before the
protocol was initiated. We can perhaps explain this situa-
tion by suggesting that the physicians who refer patients to
the NIVL for diagnostic VDUs see two groups of patients:
1, patients who they truly believe have DVT; and 2, patients
who they doubt have DVT but for whom they feel obli-
gated to exclude DVT before discharge from the ED. It is
the latter group of patients that was stratified by our pro-
gram. The program also succeeded because of our periodic
outcomes assessment and the lack of patient morbidity or
mortality and because referring physicians became increas-
ingly comfortable with the treatment options of LMWH or
observation or both. Through education, their decision-
making changed from immediate need for VDU to risk
stratification and appropriate timing for VDU studies.
In conclusion, this program has greatly reduced the num-
ber of after-hours VDU studies without a single adverse
patient outcome. The RVT retention during the initial 48
months was 100%, and the hospital has realized financial sav-
ings in respect to RVT overtime. We believe this program has
succeeded because it modified physician decision-making pro-
cesses. It has resulted in a more stable workforce in the NIVL.
We thank Nancy D. Taylor, PhD, for technical assis-
tance with the manuscript.
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Analysis of after-hours venous duplex scan studies
Time period
No. of VDU
studies after
9 PM
No. of studies
positive for
DVT
Percent of
positive
studies
No. of
deferred
studies
No. of studies
positive for
DVT
Percent of
positive
studies
Before program initiation
1997 to 1998 132 8 6 0 — —
After program initiation
1998 to 1999 16 8 50 60 1 1.6
1999 to 2000 14 3 21 101 1 1
Total (1998 to 2000) 30 11 37 161 2 1.2
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